Russell Investments Group Ltd. Has $8.68 Million Stock Holdings in Smith & Nephew plc (NYSE:SNN)

Russell Investments Group Ltd. trimmed its holdings in shares of Smith & Nephew plc (NYSE:SNN) by 10.1% during the fourth quarter, Holdings Channel.com reports. The fund owned 318,209 shares of the medical equipment provider’s stock after selling 35,938 shares during the quarter. Russell Investments Group Ltd.’s holdings in Smith & Nephew were worth $8,681,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. CWM LLC increased its position in Smith & Nephew by 68.6% during the fourth quarter. CWM LLC now owns 954 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 388 shares during the period. Allworth Financial LP increased its position in Smith & Nephew by 1,566.2% during the third quarter. Allworth Financial LP now owns 1,133 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 1,065 shares during the period. GAMMA Investing LLC bought a new position in Smith & Nephew during the fourth quarter worth about $53,000. Signaturefd LLC increased its position in Smith & Nephew by 31.3% during the third quarter. Signaturefd LLC now owns 5,322 shares of the medical equipment provider’s stock worth $132,000 after acquiring an additional 1,268 shares during the period. Finally, Seed Wealth Management Inc. bought a new position in Smith & Nephew during the fourth quarter worth about $213,000. 25.64% of the stock is owned by institutional investors.

Smith & Nephew Stock Down 0.1 %

SNN stock opened at $24.76 on Tuesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.77 and a quick ratio of 0.72. Smith & Nephew plc has a 12 month low of $21.52 and a 12 month high of $32.71. The company’s 50-day moving average price is $25.49 and its two-hundred day moving average price is $26.07.

Smith & Nephew Announces Dividend

The company also recently announced a semi-annual dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Tuesday, April 2nd will be issued a $0.462 dividend. This represents a yield of 2.8%. The ex-dividend date of this dividend is Monday, April 1st.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a report on Friday, March 15th. Three research analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.